EW Edwards Lifesciences Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
07:18
Jul 25
Jul 25
r/ValueInvesting
Edwards Lifesciences has held its value, beaten earnings estimates.
Edwards Lifesciences has held its value, beaten earnings estimates, and sees continued growth in minimally invasive heart valves; June sales and earnings also beat. Expanded Medicare coverage and an upcoming clinical trial readout provide catalysts; the stock is still at $84 with analyst target of $100 (19% upside). Edwards is a clean growth story in large-cap medtech at a reasonable valuation, offering relative safety within the sector. Clinical trial miss; Medicare policy changes; competition from newer valve technologies.
EW
Edwards Lifesciences
Long
1ST
—
—
About EW Investor Commentary
Across the available history and selected sources, Buzzberg tracks EW (Edwards Lifesciences) across 7 sources: 1 bullish vs 0 bearish calls from 10 authors. Historical directional balance: 7% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 14 total trade ideas tracked. Latest voices: u/raytoei.